AU2021349560A1 - Muscle atrophy prevention agent - Google Patents

Muscle atrophy prevention agent Download PDF

Info

Publication number
AU2021349560A1
AU2021349560A1 AU2021349560A AU2021349560A AU2021349560A1 AU 2021349560 A1 AU2021349560 A1 AU 2021349560A1 AU 2021349560 A AU2021349560 A AU 2021349560A AU 2021349560 A AU2021349560 A AU 2021349560A AU 2021349560 A1 AU2021349560 A1 AU 2021349560A1
Authority
AU
Australia
Prior art keywords
strain
nite
muscle
lactic acid
lactobacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021349560A
Other languages
English (en)
Other versions
AU2021349560A9 (en
Inventor
Daisuke Kawata
Yasuyuki Seto
Ken Ukibe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Megmilk Snow Brand Co Ltd
Original Assignee
Megmilk Snow Brand Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megmilk Snow Brand Co Ltd filed Critical Megmilk Snow Brand Co Ltd
Publication of AU2021349560A1 publication Critical patent/AU2021349560A1/en
Publication of AU2021349560A9 publication Critical patent/AU2021349560A9/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/131—Cremoris
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/137—Delbrueckii
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/157—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/231—Lactis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AU2021349560A 2020-09-23 2021-09-22 Muscle atrophy prevention agent Abandoned AU2021349560A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020158699 2020-09-23
JP2020-158699 2020-09-23
PCT/JP2021/034680 WO2022065330A1 (ja) 2020-09-23 2021-09-22 筋委縮予防剤

Publications (2)

Publication Number Publication Date
AU2021349560A1 true AU2021349560A1 (en) 2023-05-18
AU2021349560A9 AU2021349560A9 (en) 2025-01-09

Family

ID=80845441

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021349560A Abandoned AU2021349560A1 (en) 2020-09-23 2021-09-22 Muscle atrophy prevention agent

Country Status (8)

Country Link
US (1) US20230330165A1 (cg-RX-API-DMAC7.html)
EP (1) EP4241778A1 (cg-RX-API-DMAC7.html)
JP (2) JP7791828B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230074217A (cg-RX-API-DMAC7.html)
AU (1) AU2021349560A1 (cg-RX-API-DMAC7.html)
CA (1) CA3196165A1 (cg-RX-API-DMAC7.html)
TW (1) TW202229544A (cg-RX-API-DMAC7.html)
WO (1) WO2022065330A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250029895A (ko) * 2022-06-22 2025-03-05 (주)에이스바이옴 락토바실러스 가세리를 포함하는 근감소증의 예방 또는 치료용 조성물
JP2024008104A (ja) * 2022-07-07 2024-01-19 学校法人順天堂大学 高負荷運動による体調の不良化の緩和用、抑制用または予防用組成物
JP2025537795A (ja) * 2022-11-17 2025-11-20 アンスティテュート ナショナル ド ルシェルシュ プール ラグリキュルテュール,ラリマンタシォン エ ランヴィロンヌマン リモシラクトバチルス・ムコサエ(Limosilactobacillus mucosae)及びGLP-1増加を必要とする障害
KR20240147957A (ko) * 2023-03-29 2024-10-10 한국생명공학연구원 신규 비피도박테리움 및/또는 락토바실러스 속 균주 또는 이들의 조합 및 이의 용도
CN117224581A (zh) * 2023-08-31 2023-12-15 江南大学 一株具有提高运动能力作用的嗜热链球菌及其应用
JP2025534923A (ja) * 2023-09-01 2025-10-22 ラクトメイソン カンパニー リミテッド 乳清タンパク質分解能、アミノ酸生成能及び乳糖分解能の改善効果を有するプロバイオティクス組成物
CN119776241B (zh) * 2025-03-12 2025-06-13 民生中科嘉亿(山东)生物工程有限公司 改善肌少症性肥胖的乳酸乳球菌乳亚种jyll-51及其菌剂和应用
CN121718478B (zh) * 2026-02-14 2026-05-26 中科微智(北京)生物科技有限公司 一种具有减脂期肌肉保护功能的德式乳杆菌及其产品、应用
CN122128184A (zh) * 2026-04-27 2026-06-02 湖南营养树生物科技有限公司 乳脂乳球菌和发酵羊初乳制品及其制备方法和改善老年性肌肉流失的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55167125A (en) 1979-06-13 1980-12-26 Nippon Shokubai Kagaku Kogyo Co Ltd Manufacture of aqueous magnesium hydroxide dispersion
JP2005225841A (ja) * 2004-02-16 2005-08-25 Snow Brand Milk Prod Co Ltd 病原体感染防御剤
JP6333509B2 (ja) * 2012-06-22 2018-05-30 雪印メグミルク株式会社 還元された桂皮酸類縁化合物含有画分の製造方法
JP6339526B2 (ja) 2015-05-22 2018-06-06 アサヒグループホールディングス株式会社 筋肉の分解抑制剤
ITUB20155752A1 (it) * 2015-11-19 2017-05-19 Probiotical Spa Composizione di batteri per uso per attenuare le diminuzioni di prestazione dopo un esercizio fisico che danneggia i muscoli.
JP6150312B2 (ja) 2016-01-26 2017-06-21 株式会社明治 身体活動を促進させる乳酸菌
WO2018003900A1 (ja) * 2016-06-30 2018-01-04 アサヒグループホールディングス株式会社 栄養状態改善に使用するための組成物
WO2018151225A1 (ja) * 2017-02-16 2018-08-23 国立大学法人信州大学 筋分化促進剤、筋分化促進方法、筋分化促進オリゴdna、増強剤及びオリゴdna
WO2018174125A1 (ja) * 2017-03-22 2018-09-27 雪印メグミルク株式会社 脂質代謝改善用組成物
WO2019230957A1 (ja) 2018-06-01 2019-12-05 雪印メグミルク株式会社 筋修復促進用組成物
JP2020014452A (ja) * 2018-07-13 2020-01-30 株式会社明治 濃縮発酵乳の製造方法
JP6739603B1 (ja) * 2019-07-24 2020-08-12 雪印メグミルク株式会社 記憶・学習能維持および/または向上用組成物及び組成物を含む食品、医薬品、飼料

Also Published As

Publication number Publication date
AU2021349560A9 (en) 2025-01-09
JP2025172898A (ja) 2025-11-26
JPWO2022065330A1 (cg-RX-API-DMAC7.html) 2022-03-31
KR20230074217A (ko) 2023-05-26
US20230330165A1 (en) 2023-10-19
EP4241778A1 (en) 2023-09-13
WO2022065330A1 (ja) 2022-03-31
CA3196165A1 (en) 2022-03-31
JP7791828B2 (ja) 2025-12-24
TW202229544A (zh) 2022-08-01

Similar Documents

Publication Publication Date Title
US20230330165A1 (en) Muscle atrophy prevention agent
KR101279852B1 (ko) 골다공증 예방 또는 치료용 조성물
JP5686680B2 (ja) 乳酸菌発酵によるカゼイン由来ペプチドの製造方法
KR102146429B1 (ko) 비피도박테리움 아니말리스 아종 아니말리스 균주
CN116555076B (zh) 一株长双歧杆菌长亚种my1及其在制备通便和护肠食品药品中的应用
BR112012011315B1 (pt) Formulação que compreende cepa de bifidobactéria probiótica
JP6339526B2 (ja) 筋肉の分解抑制剤
TW201625284A (zh) 新穎的雷曼氏乳桿菌菌株(lactobacillus rhamnosus)與其用於抑制黃嘌呤氧化酶及治療痛風之代謝產物
US20100203026A1 (en) Probiotics for inducing satiety and/or satiation
MX2012009799A (es) Metodo para construir una nueva bacteria perteneciente al genero bifidobacterium.
CN116555075B (zh) 一株植物乳植杆菌jf1及其在制备抗衰老食品药品中的应用
Vitheejongjaroen et al. Antioxidant activity of Bifidobacterium animalis MSMC83 and its application in set-style probiotic yoghurt
JPWO2018003900A1 (ja) 栄養状態改善に使用するための組成物
US20240316127A1 (en) Method for increasing calcium absorption using culture of bifidobacterium animalis subsp. lactis cp-9
CN101983065B (zh) 脂连蛋白分泌促进和/或降低抑制剂
WO2022151669A1 (en) Lactobacillus amylovorus lam1345 isolate, composition including the same and use thereof
KR102049970B1 (ko) 락토바실러스 카제이 hy2782를 유효성분으로 함유하는 미세먼지로 인한 산화적 스트레스를 개선하기 위한 조성물
KR20200145941A (ko) 락토바실러스 카제이 hy2782를 유효성분으로 함유하는 미세먼지에 의한 밀착연접단백질 관련 질환의 예방 또는 개선용 식품조성물
JP7627369B2 (ja) 糖吸収促進用組成物
US20250073289A1 (en) Method for increasing calcium absorption using culture of lactobacillus rhamnosus mp108
JP7716170B2 (ja) エリスロポエチン産生促進用組成物
WO2017175774A1 (ja) インターフェロンλ産生促進用組成物及びその製造方法
JP7606276B2 (ja) 脂質代謝改善用組成物
Nováková et al. Identification of Enterococcus sp. in GIT of Broiler Chickens after Application of Biological Preparations

Legal Events

Date Code Title Description
SREP Specification republished
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period